Results 111 to 120 of about 1,552 (162)

Sarcoglycans are enriched at the neuromuscular junction in a nerve-dependent manner. [PDF]

open access: yesCell Death Dis
Gloriani M   +10 more
europepmc   +1 more source

Arrhythmogenic Cardiomyopathy Diagnosed Late in a Master Recreational Endurance Athlete. [PDF]

open access: yesJACC Case Rep
Gardikioti V   +9 more
europepmc   +1 more source

Erythrokeratodermia Variabilis due to a Compound Heterozygous Variants in the NIPAL4 Gene. [PDF]

open access: yesPediatr Dermatol
Sánchez-Espino LF   +5 more
europepmc   +1 more source

From Misdiagnosis to Discovery: Expanding the Spectrum of Spliceosomopathies. [PDF]

open access: yesGenes (Basel)
Marchetti GB   +9 more
europepmc   +1 more source

Mutational spectrum of sarcoglycanopathies in Spain

open access: yes, 2011
Castro Gago, Manuel   +1 more
openaire   +1 more source

Emerging therapeutic strategies for sarcoglycanopathy

open access: yesExpert Opinion on Orphan Drugs, 2017
Introduction: Sarcoglycanopathy is the name shared by four rare autosomal recessive muscular dystrophies (LGMD2 C-F) that are usually characterized by early onset and rapid progression and an accompanying loss of independent walking since adolescence ...
Dorianna Sandonà, Marcello Carotti
exaly   +3 more sources

New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy

open access: yesBrain, 2020
Sarcoglycanopathies comprise four subtypes of autosomal recessive limb-girdle muscular dystrophies (LGMDR3, LGMDR4, LGMDR5 and LGMDR6) that are caused, respectively, by mutations in the SGCA, SGCB, SGCG and SGCD genes.
Cristina Dominguez-Gonzalez   +2 more
exaly   +8 more sources

Home - About - Disclaimer - Privacy